Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-02-04 5:16 pm |
N/A 2030-08-12 |
Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer |
0 | $0 | 949,197 (Direct) |
View |
Ownership |
2021-02-04 5:15 pm |
N/A 2029-01-10 |
Terns Pharmaceuticals Inc. | TERN | Quirk Erin See Remarks |
0 | $0 | 379,678 (Direct) |
View |
Ownership |
2021-02-04 5:14 pm |
N/A 2030-09-09 |
Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer |
0 | $0 | 227,807 (Direct) |
View |
Ownership |
2021-02-04 5:13 pm |
N/A 2030-12-29 |
Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan See Remarks |
0 | $0 | 265,775 (Direct) |
View |
Ownership |
2021-02-04 5:12 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Zhong Weidong Chief Scientific Officer |
0 | $0 | 513,520 (Direct) |
View |
Ownership |
2021-02-04 5:11 pm |
N/A 2030-12-29 |
Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director |
0 | $0 | 28,475 (Direct) |
View |
Ownership |
2021-02-04 5:10 pm |
N/A 2030-12-29 |
Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director |
0 | $0 | 28,475 (Direct) |
View |
Ownership |
2021-02-04 5:09 pm |
N/A 2030-12-29 |
Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director |
0 | $0 | 28,475 (Direct) |
View |
Ownership |
2021-02-04 5:07 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner |
0 | $0 | 3,316,204 (Indirect) |
View |
Ownership |
2021-02-04 5:07 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner |
0 | $0 | 3,316,204 (Indirect) |
View |
Ownership |
2021-02-04 5:05 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner |
0 | $0 | 2,200,133 (Indirect) |
View |
Ownership |
2021-02-04 5:01 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | LAV Biosciences Fund V L.P. Hopewell Resources Holdings Ltd Oriental Spring Venture Ltd LAV Aqua Ltd 10% Owner |
0 | $0 | 4,781,566 (Indirect) |
View |